Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam

QR Code

Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam

Huyen Thi Phung,1 Hoa Thi Nguyen,1 Tung Van Nguyen,1 Tai Van Nguyen,2 Lan Anh Thi Dinh,3 Chu Van Nguyen4 1Department of Medical Oncology 6, National Cancer Hospital of Vietnam, Hanoi, Vietnam; 2Department of Medical Oncology 1, National Cancer Hospital of Vietnam, Hanoi, Vietnam; 3Department of Opti...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Phung HT, Thi Nguyen H, Nguyen TV, Dinh LAT, Nguyen CV
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2020
Sujets:	pathological response neoadjuvant breast cancer trastuzumab chemotherapy. Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/023a89efac4242d39900e883f68a3c46
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review
par: Ana Julia Aguiar de Freitas, et autres
Publié: (2021)

Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram
par: Hao Cui, et autres
Publié: (2021)

Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancer
par: Kamil D. Dalgatov, et autres
Publié: (2021)

Association of tumor‐infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer
par: Jin Hong, et autres
Publié: (2021)

Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment
par: Perelmuter VM, et autres
Publié: (2019)

Characteristics and Risk Factors of Postoperative Complications in Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy
par: SUN Chongyuan, et autres
Publié: (2021)

Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy
par: Sales ACV, et autres
Publié: (2020)

A Comparison of Different Schemes of Neoadjuvant Chemotherapy Followed by Concurrent Chemotherapy and Radiotherapy for Locally Advanced Cervical Cancer: A Retrospective Study
par: Tian X, et autres
Publié: (2021)

The Influence of Lymph Node Count on Oncological Outcome of Radical Cystectomy in Chemotherapy Pre-Treated and Chemotherapy-Naïve Patients with Muscle Invasive Bladder Cancer
par: Artur Lemiński, et autres
Publié: (2021)

Influence of correction of nutritive deficiency on the effectiveness of neoadjuvant chemotherapy in patients with locally advanced gastric cancer
par: Nadezhda A. Brish, et autres
Publié: (2021)

Neoadjuvant therapy strategies for advanced gastric cancer: Current innovations and future challenges
par: Zhi Zhu, et autres
Publié: (2020)

A single-nucleotide polymorphism of the beta 2-adrenergic receptor gene can predict pathological complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer
par: Du Y, et autres
Publié: (2018)

Machine Learning-Based Radiomics Nomogram With Dynamic Contrast-Enhanced MRI of the Osteosarcoma for Evaluation of Efficacy of Neoadjuvant Chemotherapy
par: Lu Zhang, et autres
Publié: (2021)

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
par: Hyder T, et autres
Publié: (2021)

A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
par: Bingqing Xia, et autres
Publié: (2021)

Reversible cardiotoxicity in a 54-year-old woman treated with trastuzumab
par: Martins,Sandro José, et autres
Publié: (2012)

A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin
par: Mitchell Clark, et autres
Publié: (2021)

Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review
par: Linehan AS, et autres
Publié: (2021)

Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
par: Jesse Lopes da Silva, et autres
Publié: (2021)

Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer
par: Ze-Rui Zhao, et autres
Publié: (2021)

Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data
par: Jagosky M, et autres
Publié: (2021)

Application of Gross Tissue Response System in Gastric Cancer After Neoadjuvant Chemotherapy: A Primary Report of a Prospective Cohort Study
par: Hua Yang, et autres
Publié: (2021)

Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II, single-arm, multicenter study
par: Puhalla S, et autres
Publié: (2016)

Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis
par: Yuanfang Xin, et autres
Publié: (2021)

Intraoperative and postoperative outcomes of Harmonic Focus versus monopolar electrocautery after neoadjuvant chemotherapy in breast conservative surgery: a comparative study
par: Islam Khaled, et autres
Publié: (2021)

Elevated Level of Nerve Growth Factor (NGF) in Serum-Derived Exosomes Predicts Poor Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy
par: Hae Hyun Jung, et autres
Publié: (2021)

Decrease in Blood Neutrophil-to-Lymphocyte Ratio Indicates Better Survival After Neoadjuvant Chemotherapy in Patients With Advanced Gastric Cancer
par: Ziyi Liu, et autres
Publié: (2021)

Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment
par: da Silva JL, et autres
Publié: (2021)

Neoadjuvant chemotherapy for advanced stage endometrial cancer: A systematic review
par: Allan B. Huang, et autres
Publié: (2021)

Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
par: Yunhai Li, et autres
Publié: (2021)

Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial
par: Mitsuro Kanda, et autres
Publié: (2021)

Neoadjuvant chemotherapy for Ewing’s sarcoma family tumors of the uterine cervix: A case report
par: Masahiko Mori, et autres
Publié: (2021)

Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study
par: Peng Yang, et autres
Publié: (2021)

The Role of Trastuzumab in Patients with HER2 Positive Small (pT1mi/a) Breast Cancers, a Multicenter Retrospective Study
par: Andrea Villasco, et autres
Publié: (2021)

Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literature
par: Belal Firwana, et autres
Publié: (2012)

Impact of dose-dense neoadjuvant chemotherapy on pathologic response and survival for HER2-positive breast cancer patients who receive trastuzumab
par: Lize Wang, et autres
Publié: (2021)

Pathological Complete Response to Neoadjuvant Chemotherapy in a Patient with HER2-Positive Squamous Cell Carcinoma of the Breast
par: Yuki Usui, et autres
Publié: (2021)

The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers
par: Hye Ryeon Kim, et autres
Publié: (2021)

Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer
par: Salkeni MA, et autres
Publié: (2021)

Neoadjuvant immunotherapy combined with chemotherapy for locally advanced squamous cell lung carcinoma: A case report and literature review
par: Zheng Yuan, et autres
Publié: (2021)